Compare HOWL & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOWL | HYPR |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.5M | 104.0M |
| IPO Year | 2021 | N/A |
| Metric | HOWL | HYPR |
|---|---|---|
| Price | $0.64 | $1.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $6.50 | $1.28 |
| AVG Volume (30 Days) | ★ 851.9K | 763.0K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,591,000.00 |
| Revenue This Year | N/A | $5.17 |
| Revenue Next Year | N/A | $35.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.53 |
| 52 Week High | $2.38 | $2.22 |
| Indicator | HOWL | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 32.32 | 50.17 |
| Support Level | $0.61 | $0.91 |
| Resistance Level | $0.74 | $1.18 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 14.30 | 55.56 |
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.